Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06216002 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

Study acronym: FIGO
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 356 participants (planned 622) · Primary completion date changed from estimate of Dec 31, 2025 to Sep 30, 2025 · Start date: Jan 2, 2024 to Nov 12, 2023 · 3 more Show 6 more changesShow less
    • Final enrollment: 356 participants (planned 622)
    • Primary completion date changed from estimate of Dec 31, 2025 to Sep 30, 2025
    • Start date: Jan 2, 2024 to Nov 12, 2023
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 2 of 9 entries
    • Site details revised
  2. Primary completion date: Dec 31, 2024 to Dec 31, 2025 Completion date: Jun 30, 2025 to Dec 31, 2025 · Site details revisedv2 Show 2 more changesShow less
    • Completion date: Jun 30, 2025 to Dec 31, 2025
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.
Trial Details
NCT Number NCT06216002
Lead Sponsor Mahidol University
Conditions Frailty, Neuromuscular Blockade, General Anesthetic Drug Adverse Reaction, Gynecologic Cancer, Surgical Complication
Enrollment 356 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov